Mercaptoacetic acid (RSH)-capped CdS nanocrystals (NCs) was demonstrated to be electrochemically reduced during potential scan and react with the coreactant S2O8(2-) to generate strong electrochemiluminescence (ECL) in aqueous solution. Based on the ECL of CdS NCs, a novel label-free ECL biosensor for the detection of low-density lipoprotein (LDL) has been developed by using self-assembly and gold nanoparticle amplification techniques. The biosensor was prepared as follows: The gold nanoparticles were first assembled onto a cysteamine monolayer on the gold electrode surface. This gold nanoparticle-covered electrode was next treated with cysteine and then reacted with CdS NCs to afford a CdS NC-electrode. Finally, apoB-100 (ligand of LDL receptor) was covalently conjugated to the CdS NC-electrode. The modification procedure was characterized by cyclic voltammetry, electrochemical impedance spectroscopy, and atomic force microscopy, respectively. The resulting modified electrode was tested as ECL biosensor for LDL detection. The LDL concentration was measured through the decrease in ECL intensity resulting from the specific binding of LDL to apoB-100. The ECL peak intensity of the biosensor decreased linearly with LDL concentration in the range of 0.025-16 ng mL-1 with a detection limit of 0.006 ng mL-1. The CdS NCs not only showed high ECL intensity and good biocompatibility but also could provide more binding sites for apoB-100 loading. In addition, the gold nanoparticle amplification for protein ECL analysis was applied to the improvement of the detection sensitivity. Thus, the biosensor exhibited high sensitivity, good reproducibility, rapid response, and long-term stability.

A novel strategy for the enhancement of electrochemiluminescence (ECL) was developed by combining CdSe nanocrystals (NCs), carbon nanotube-chitosan (CNT-CHIT), and 3-aminopropyl-triethoxysilane (APS). A label-free ECL immunosensor for the sensitive detection of human IgG (HIgG) was fabricated. The colloidal solution containing CdSe NCs/CNT-CHIT composite was first covered on the Au electrode surface to form a robust film, which showed high ECL intensity and good biocompatibility. After APS as a cross-linker was covalently conjugated to the CdSe NCs/CNT-CHIT film, the ECL intensity was greatly enhanced. And, an intensity about 20-fold higher than that of the CdSe NCs/CNT-CHIT film was observed. After antibody was bound to the functionalized film via glutaric dialdehyde (GLD), the modified electrode could be used as an ECL immunosensor for the detection of HIgG. The specific immunoreaction between HIgG and antibody resulted in the decrease in ECL intensity. The ECL intensity decreased linearly with HIgG concentration in the range of 0.02-200 ng mL(-1), and the detection limit was 0.001 ng mL(-1). The immunosensor has the advantages of high sensitivity, speed, specificity, and stability and could become a promising technique for protein detection.

In this work, a novel dendrimer/CdSe-ZnS-quantum dot nanocluster (NC) was fabricated and used as an electrochemiluminescence (ECL) probe for versatile assays of cancer cells for the first time. A large number of CdSe-ZnS-quantum dots (QDs) were labeled on the NCs due to the many functional amine groups within the NCs, which could significantly amplify the QD's ECL signal. Capture DNA was specially designed as a high-affinity aptamer to the target cell; a novel ECL biosensor for cancer cells was directly accomplished by using the biobarcode technique to avoid cross-reaction. Moreover, magnetic beads (MBs) for aptamers immobilization were combined with the dendrimer/QD NCs probe for signal-on ECL assay of cancer cells, which greatly simplified the separation procedures and favored for the sensitivity improvement. In particular, a novel cycle-amplifying technique using a DNA device on MBs was further employed in the ECL assay of cancer cells, which greatly improved the sensitivity. To the best of our knowledge, this is the first study that the novel dendrimer/QD NCs probe combined with a DNA device cycle-amplifying technique was employed in the ECL assays of cells. Excellent discrimination against target and control cells is demonstrated, indicating that the ECL assays have great potential to provide a sensitive, selective, cost-effective, and convenient approach for early and accurate detection of cancer cells.

No abstract

The highly enhanced electrochemiluminescence from a novel hybrid gold/silica/CdSe-CdS quantum-dot nanostructure has been reported for the first time, and successfully applied to develop an ultrasensitive ECL immunosensor for the detection of a protein tumor marker, carcinoembryonic antigen.